About one in every five people carries a version of a gene that, although largely unsung, appears to confer protection against both Alzheimer’s disease and Parkinson’s disease, Stanford Medicine investigators and their colleagues have learned.
Digital therapeutics firm Akili to sell for $34M
Dive Brief: Dive Insight: Akili was one of a few companies that sought to develop prescription apps, called digital therapeutics, that have received the FDA’s
May 31, 2024